Abnormal Uterine Bleeding Dr Helen Barnes GPSI September 2014.

Slides:

Advertisements

Similar presentations

Managing Heavy Menstrual Bleeding

Advertisements

Minimum Access Techniques for D.U.B.

Dr Kristina Naidoo Consultant Gynaecologist

 Common referral to the menorrhagia clinic  Need to know- what it is - how to diagnose it - recognise red flags - treatments in gp -when to refer 

 Ultrasound pelvis  Full blood count  Pap smear  Coagulation profile  Liver function tests  Serum Iron  Serum ferritin  Endometrial biopsy 

Abnormal uterine bleeding King Khalid University Hospital Department of Obstetrics & Gynecology Course 481 Tutorials.

Max Brinsmead PhD FRANZCOG January 2010

Common Gynaecological Disorders Dr. Lee Chin Peng Honorary Clinical Associate Professor Department of Obstetrics and Gynaecology University of Hong Hong.

By Dr Rukhsana Hussain ST1 17 th November Objectives To increase awareness of menorrhagia, its causes and impact on individuals and society To cover.

Disorders of the Menstrual Cycle

ABNORMAL UTERINE BLEEDING Dr Rooma Sinha, MD, DNB Senior Consultant Gynecologist & Laparoscopic Surgeon Apollo Health City; HYDERABAD

Abnormal Vaginal Bleeding in a 56 year old Max Brinsmead PhD FRANZCOG May 2015.

Abnormal uterine bleeding

DYSFUNCTIONAL UTERINE BLEEDING

Abnormal Uterine Bleeding

Heavy Menstrual Bleeding.  Also called menorrhagia  Excessive menstrual bleeding which interferes with a woman’s physical, social, emotional or material.

Post Menopausal Bleeding

Management of Abnormal Vaginal Bleeding

Dysfunctional Uterine Bleeding. DUB is defined as abnormal uterine bleeding in the absence of any organic lesion in the genital tract. Most common occurs.

Dr. HANA OMER Abnormal Uterine Bleeding (AUB) 2014.

Max Brinsmead MB BS PhD May  Listening to the patient tell her story  Generating a hypothesis  Testing the hypothesis ▪ By interrogation ▪ 50.

DR MANAL IDRIS menorrhagia. Introduction Menorrhagia is one of the commenest gynaecological complaints seen in practice and accounts for approximately.

Heavy Menstrual Bleeding Max Brinsmead MB BS PhD Mayy 2015.

Normal and Abnormal Uterine Bleeding

Academic Year MSIII Ob/Gyn Clerkship Self-Directed Study

Management of Heavy Menstrual Bleeding Dr Sana’a Sabri GP ST1 14/12/2010.

Mr James Campbell FRCOG

MENSTRUAL CYCLE DISORDERS THERAPY

Management of Abnormal Vaginal Bleeding D.W Polson Consultant Obstetrician & Gynaecologist.

Post-menopausal bleeding PV Dr Nasira Sabiha Dawood.

Monday, August 8 th,  Normal cycle lasts: 26 to 30 days, but may vary from 21 to 35 days  Normal menstrual flow lasts: 3 to 7 days A period.

Unscheduled bleeding in young women Dr Kathryn Hill GPST2 in O+G.

Menstrual Disorders Geetha Kamath, M.D. Dept. of Medicine West Virginia University.

ABNORMAL UTERINE BLEEDING

1 Guildford & Waverley Community Gynaecology Service September 2014 Presented by Dr Helen Barnes.

In the Name of God. Abnormal perimenopausal and Postmenopausal Bleeding F.Behnamfar GYNECOLOGY ONCOLOGY FELLOWSHIP KASHAN UNIVERSITY OF MEDICAL SCIENCES.

Abnormal uterine bleeding King Khalid University Hospital Department of Obstetrics & Gynecology Course 481 Tutorials.

A BNORMAL UTERINE BLEEDING Dr.Srwa Jamal Murad MBChB,FICOG.

Max Brinsmead MB BS PhD May The common causes are…  Pregnancy-related ○ Miscarriage – threatened, inevitable or incomplete ○ Ectopic  Cervical.

Heavy Menstrual Bleeding for Undergraduates Max Brinsmead MB BS PhD May 2015.

Prof Lindeque Abnormal excessive uterine bleeding.

Uterine Fibroids for Undergraduates

Vaginal Bleeding in the Perimenopause (Age 35-50)

Abnormal Uterine Bleeding

ABNORMAL UTERINE BLEEDING

 Combined OC with 20 ug EE  Combined OC with 50 ug EE  Oral iron  Intramuscular iron  NSAID  Tranexamic acid (Cyklokapron)  Ethamsylate  Primolut.

Heavy periods. History Before % ended up with hysterectomy Since 1990 – rapid decrease in hysterectomy Family history May influence patient expectation.

Coin in the palm.

PV Bleeding: a case presentation John Alabi GPST323/10/12.

Heavy menstrual bleeding Implementing NICE guidance January 2007 NICE clinical guideline 44.

MENORRHAGIA – AN OVERVIEW

A BNORMAL M ENSTRUATION Matthew Beaumont. H EAVY / A BNORMAL M ENSTRUAL B LEEDING Menorrhagia Excessive bleeding in normal cycle Clinical definition:

Diagnosis & Management of Abnormal Uterine Bleeding in Reproductive Period FOGSI Nomenclature (PALM-COEIN CLASSIFICATION) Evidence Based AUB guidelines.

Approach to Abnormal Uterine Bleeding

Abnormal uterine bleeding

European Board and College of Obstetrics and Gynaecology

Abnormal Vaginal Bleeding In Adults

Changes before the change: Perimenopausal Bleeding

Endometrial hyperplasia

Mr Pratik N Shah MD MRCOG Clinical Director for Womens Services

ENDOMETRIAL HYPERPLASIA

Dr. Aya M. Serry Abnormal Uterine Bleeding (AUB) 2016

Changes before the change: Perimenopausal Bleeding

Dr Fulufhelo Tshivhula Specialist Gynaecologist Polokwane

Case Study 3 - Menorrhagia

Changes before the change: Perimenopausal Bleeding

ABNORMAL UTERINE BLEEDING (AUB)

Dysfunctional Uterine Bleeding

Presentation transcript:

Abnormal Uterine Bleeding Dr Helen Barnes GPSI September 2014

Terminology Abnormal Uterine Bleeding: Any bleeding from the uterus that is either abnormal in volume, regularity or timing. Encompasses HMB, IMB, PCB* & PMB* Heavy Menstrual Bleeding: Excessive menstrual loss interfering with quality of life, can occur alone or with other symptoms. Intermenstrual Bleeding: Uterine bleeding that occurs between clearly defined predictable cycles. The timing of IMB can be regular (predictable) or irregular (random). PCB & PMB can be uterine in origin but they can also be caused by other genital tract pathology.

Terminology con’t Terms no longer preferred: Menorrhagia Dysfunctional uterine bleeding Polymenorrhoea Metrorrhagia AUB is best described according to four components: frequency, duration, volume, regularity.

Classification FIGO 2011: PALM- COEIN Structural vs non-structural Can have more than one pathology co-existing.

Risk factors for hyperplasia Age > 45yrs Obesity (BMI > 30) Anovulatory cycles (PCOS) Persistent IMB Medical treatment failure Unopposed oestrogen or tamoxifen use.

Assessment *Uterine evaluation: history +/- examination +/- cx smear +/- STI screen +/- bloods

Treatment of AUB No discrete structural or histological cause, or fibroids < 3cm 1 st line if acceptable to patient is IUS Medical Management (step 1): Tranexamic acid (decrease 30-50%) NSAIDS (decrease 20-40%) COC (decrease 40%) Oral progestogen (high dose) (decrease 60%)* IUS (decrease %) GnRH analogues (3-6m) (decrease %) Progestogen only implant or depot (decrease %) * norethisterone is metabolised to EE, 15mg a day equivalent to 30mcg COC!

Treatment continued Minimally invasive uterus conserving surgery (step 2): Endometrial Ablation (decrease 80%) Transcervical resection of endometrium (TCRE) (decrease %) Major surgery (step 3): Hysterectomy (complete cure) Future consideration – EA vs hysterectomy

Treatment continued For AUB – L where fibroids are > 3cm with significant impact on QAL: Hysteroscopic Myomectomy (decrease 50-80%) Laparoscopic Myomectomy (0-30% decrease) Uterine artery emobolisation (60-80% decrease) Hysterectomy (100%)